STAFF BOARD
Article
CHAIRMAN
Maruxa Hernández Corredoira
EDITOR IN CHIEF
Manuela Velázquez Prieto
Tomás Casasín Edo
MARKETING MANAGER
EDITORIAL BOARD
María B. Badía Tahull
Lluís Campins Bernadas
Juan Carlos Juárez Giménez
Carles Quiñones Ribas
Volume 23 - Issue 3, July-September 2021
SHORT REPORTS
CEFOTAXIME DOSING REGIMEN FOR THE TREATMENT OF NEONATAL SEPSIS: DOSING GUIDELINE VARIATION EVALUATION AND CONSEQUENCES
AHMER RAZA MUHAMMAD, AZIZ SHIREEN, SHAHZAD SANA, MAS OOD RAZA SHAHID



Neonatal bacterial sepsis is a major common disease that threatens the life of newborns, not only has a high incidence rate but also has a high mortality. After the diagnosis of neonatal sepsis, the rational use of antibiotics is the primary treatment measure. In cases where antibiotics are indicated, treatment should be based on the dosing guidelines. Standard dosing guidelines are systematically developed statements to help practitioners or prescribers to make decisions about the appropriate treatment for specific clinical conditions. Even though guidelines are available for the optimal management, compliance is a problem and varies from country to country due to significant variation. Such variations in current dosing recommendations and non-compliance may result in selection of inadequate doses or inappropriate dosing intervals for the treatment ultimate result in under-dosing, over-dosing and therapeutic failures. Since neonates are immune-compromised and are suspected to infections, such consequences can be fatal.

CONSEQUENCES – DOSING GUIDELINES – NEONATAL SEPSIS – VARIATION




Fill out the form below to buy this article

Name and surname:

DNI/NIF ID/VAT IDENTIFICATION No.:

Contact Email:

Phone:

Address:

Zip code:

City:

Province:

Country:

*I have read and accept the privacy policy
Price : 30,25